Under den indledende behandling optrådte større blødninger hos 1, 1% af de patienter, der fik fonda - parinux, over for 1, 2% af dem, der fik enoxaparin.
Major bleeding during the initial treatment period was observed in 1.1% of fondaparinux patients, compared to 1.2% with enoxaparin.